Richard Brian Gaynor's most recent trade in Zai Lab Limited - ADR was a trade of 10,831 American Depositary Shares done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Limited - ADR | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 54,899 (0%) | 0% | 0 | American Depositary Shares | |
| Alkermes plc | Richard Brian Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Richard Brian Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 33,008 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Richard Brian Gaynor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.61 per share. | 31 May 2025 | 1,924 | 31,084 (0%) | 0% | 30.6 | 58,894 | Ordinary Shares |
| Alkermes plc | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,474 | 13,474 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 6,142 | 6,142 | - | - | Restricted Stock Unit Award | |
| Zai Lab Limited - ADR | Richard Brian Gaynor | Director | Sale of securities on an exchange or to another person at price $ 35.07 per share. | 05 Mar 2025 | 2,500 | 44,068 (0%) | 0% | 35.1 | 87,675 | American Depositary Shares |